Evidence map›Paper›PMID 41977520›Full record

ArticleInternational journal of molecular sciences2026

Correction: Ly et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis.

Thanh Truong Giang Ly, Jisoo Yun, Jong-Seong Ha, Yeon-Ju Kim, Woong-Bi Jang, Thi Hong Van Le, Vinoth Kumar Rethineswaran, Jaewoo Choi, Jae-Ho Kim, Sang-Hyun Min and 4 more

Abstract readPublished Erratum
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Thanh Truong Giang LyLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
Jisoo YunLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
Jong-Seong HaLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.ORCID 0000-0001-5804-2607
Yeon-Ju KimLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
Woong-Bi JangLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.ORCID 0000-0003-4919-2202
Thi Hong Van LeLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
Vinoth Kumar RethineswaranLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
Jaewoo ChoiLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.ORCID 0000-0002-0096-4227
Jae-Ho KimConvergence Stem Cell Research Center, Pusan National University, Yangsan 50612, Republic of Korea.ORCID 0000-0003-4323-4790
Sang-Hyun MinNew Drug Development Center, Deagu Gyeongbuk Medical Innovation Foundation, Deagu 41061, Republic of Korea.
Dong-Hyung LeeDepartment of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
Ju-Seok YangDepartment of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.ORCID 0000-0002-9412-6565
Joo-Seop ChungDepartment of Hematology-Oncology, Pusan National University Hospital Medical Research Institute, Busan 49241, Republic of Korea.ORCID 0000-0001-7008-245X
Sang-Mo KwonLaboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.

Funding

Korean Health Technology R&D Project HI18C2458Korean Health Technology R&D Project, Ministry of Health and Welfare HI18C2459National Research Foundation of Korea 2021R1I1A3055686National Research Foundation of Korea NRF-2015R1A5A2009656National Research Foundation of Korea NRF-2020R1A2C2101297
6 · The paper itself

Abstract

There was an error in the representative H&E staining images in Figure 6h in the original publication [...].

Identifiers

PMID41977520
PMCPMC13072810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.